Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
QuintilesIMS
Fuji
Julphar
Harvard Business School
Deloitte
UBS
Express Scripts
Cerilliant

Generated: July 17, 2018

DrugPatentWatch Database Preview

Clidinium bromide - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for clidinium bromide and what is the scope of clidinium bromide patent protection?

Clidinium bromide
is the generic ingredient in one branded drug marketed by Roche and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for clidinium bromide.
Summary for clidinium bromide
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 6
Bulk Api Vendors: 45
Patent Applications: 983
DailyMed Link:clidinium bromide at DailyMed
Synonyms for clidinium bromide
(+-)-3-Hydroxy-1-methylquinuclidinium bromide benzilate
(1-methyl-1-azoniabicy-clo[2.2.2]oct-8-yl) 2-hydroxy-2,2-diphenyl-acetate bro-mide
(1-methyl-1-azoniabicyclo[2.2.2]octan-3-yl) 2-hydroxy-2,2-diphenylacetate bromide
(1-methyl-1-azoniabicyclo[2.2.2]octan-3-yl) 2-hydroxy-2,2-diphenylacetate;bromide
(1-methyl-1-azoniabicyclo[2.2.2]octan-3-yl) 2-oxidanyl-2,2-diphenyl-ethanoate bromide
(1-methyl-1-azoniabicyclo[2.2.2]octan-8-yl) 2-hydroxy-2,2-diphenylacetate bromide
(1-methylquinuclidin-1-ium-3-yl) 2-hydroxy-2,2-diphenyl-acetate bromide
1-Azoniabicyclo(2.2.2)octane, 3-((hydroxydiphenylacetyl)oxy)-1-methyl-, bromide
1-Azoniabicyclo(2.2.2)octane, 3-((hydroxydiphenylacetyl)oxy)-1-methyl-, bromide, (+-)-
1-Azoniabicyclo[2.2.2]octane, 3-[(hydroxydiphenylacetyl)oxy]-1-methyl-, bromide
1-Methyl-3-(benziloyloxy)quinuclidinium bromide
1-Methyl-3-benzil-oxyloxy-quinuclidinium bromide
1-methylquinuclidin-3-yl 2-hydroxy-2,2-diphenylacetate, bromide
2-hydroxy-2,2-diphenylacetic acid (1-methyl-1-azoniabicyclo[2.2.2]octan-3-yl) ester bromide
3-(2,2-Diphenyl-2-hydroxyethanoyloxy)-quinuclidinium bromide
3-(Benziloyloxy)-1-methylquinuclidinium bromide
3-{[hydroxy(diphenyl)acetyl]oxy}-1-methyl-1-azoniabicyclo[2.2.2]octane bromide
3-Hydroxy-1-methylquinuclidinium bromide benzilate
3485-62-9
7020-55-5 (Parent)
A822441
AB1008569
AC-13157
AC1L2D9C
AK-48844
AKOS015895118
AN-20225
API0002050
AX8001508
Bromure de clidinium
Bromure de clidinium [INN-French]
Bromuro de clidinio
Bromuro de clidinio [INN-Spanish]
C22H26NO3
CAS-3485-62-9
CCG-38925
CHEBI:3744
CHEMBL1200950
Clidinii bromidum
Clidinii bromidum [INN-Latin]
Clidinium (bromide)
Clidinium bromide (USP/INN)
Clidinium bromide [USAN:INN:BAN]
clidinium bromide bromide
CS-4737
D00716
DSSTox_CID_2835
DSSTox_GSID_22835
DSSTox_RID_76750
DTXSID7022835
EINECS 222-471-3
FT-0634879
HE005197
HE337243
HMS1570F05
HMS1920O15
HMS2091E22
HMS2097F05
HMS2230L12
HMS3370H21
HMS502C20
HY-B1132
I06-0406
J-019784
KB-276168
KS-1295
LS-143176
MCULE-6671202274
MLS000028560
MLS001148169
MLS002222158
MolPort-003-666-147
NCGC00016630-01
NCGC00018171-06
NCGC00094625-01
NCGC00094625-02
NCGC00094625-03
NCGC00094625-04
NSC-756686
NSC756686
Opera_ID_114
Pharmakon1600-01500192
Prestwick_71
Quarzan
Quarzan (TN)
Quarzan bromide
Quinuclidinium, 3-hydroxy-1-methyl-, bromide, benzilate
Quinuclidinol methylbromide, benzilate
REGID_for_CID_19004
Ro 2-3773
SCHEMBL99017
SCHEMBL99018
SMR000058806
SMR000058806CLIDINIUM BROMIDE
SPECTRUM1500192
SR-01000000078
SR-01000000078-2
ST51014934
Tox21_110535
Tox21_110535_1
VA10607

US Patents and Regulatory Information for clidinium bromide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche QUARZAN clidinium bromide CAPSULE;ORAL 010355-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Roche QUARZAN clidinium bromide CAPSULE;ORAL 010355-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Johnson and Johnson
Cerilliant
McKesson
Queensland Health
US Department of Justice
Express Scripts
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.